ProShare Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $274K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $208K | Sell |
|
|||||
|
2024
Q2 | $287K | Sell |
|
|||||
|
2024
Q1 | $497K | Buy |
|
|||||
|
2023
Q4 | $453K | Sell |
|
|||||
|
2023
Q3 | $293K | Buy |
|
|||||
|
2023
Q2 | $686K | Sell |
|
|||||
|
2023
Q1 | $1.25M | Sell |
|
|||||
|
2022
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q3 | $1.44M | Buy |
|
|||||
|
2022
Q2 | $836K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Sell |
|
|||||
|
2021
Q4 | $1.38M | Buy |
|
|||||
|
2021
Q3 | $886K | Sell |
|
|||||
|
2021
Q2 | $1.98M | Buy |
|
|||||
|
2021
Q1 | $1.17M | Buy |
|
|||||
|
2020
Q4 | $1.43M | Buy |
|
|||||
|
2020
Q3 | $590K | Sell |
|
|||||
|
2020
Q2 | $661K | Buy |
|
|||||
|
2020
Q1 | $366K | Sell |
|
|||||
|
2019
Q4 | $626K | Sell |
|
|||||
|
2019
Q3 | $548K | Buy |
|
|||||
|
2019
Q2 | $565K | Sell |
|
|||||
|
2019
Q1 | $448K | Buy |
|
|||||
|
2018
Q4 | $302K | Buy |
|